| Identification | Back Directory | [Name]
L-Leucine, L-alanyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-glutaminyl-L-leucyl-L-glutaminyl-L-leucyl-L-α-aspartyl-L-α-glutamyl-L-α-glutamyl-L-threonylglycyl-L-α-glutamyl-L-phenylalanyl- | [CAS]
1364173-77-2 | [Synonyms]
L-Leucine, L-alanyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-glutaminyl-L-leucyl-L-glutaminyl-L-leucyl-L-α-aspartyl-L-α-glutamyl-L-α-glutamyl-L-threonylglycyl-L-α-glutamyl-L-phenylalanyl- | [Molecular Formula]
C86H124N18O28 | [MOL File]
1364173-77-2.mol | [Molecular Weight]
1858.01 |
| Chemical Properties | Back Directory | [Boiling point ]
2142.1±65.0 °C(predicted) | [density ]
1.322±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
3.40±0.10(predicted) | [Sequence]
Ala-Phe-Phe-Ala-Gln-Leu-Gln-Leu-Asp-Glu-Glu-Thr-Gly-Glu-Phe-Leu |
| Hazard Information | Back Directory | [Uses]
Nrf2 (69-84) is a peptide fragment of Nrf2 protein that contains the key ETGE motif, which is an important region for binding to the Kelch domain of Keap1 protein. Nrf2 (69-84) can be used to study the role of Nrf2 in the development and progression of diseases, especially in cancer, neurodegenerative diseases and inflammatory diseases[1]. | [References]
[1] Chen Y, et al. Kinetic analyses of Keap1–Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance[J]. Chemical biology & drug design, 2011, 78(6): 1014-1021. DOI:10.1111/j.1747-0285.2011.01240.x |
|
| Company Name: |
Fuan Bio
|
| Tel: |
15002819872 |
| Website: |
fuanbio.com |
|